Litigation Details for Duke University v. Alcon Laboratories, Inc. (D. Del. 2018)

Duke University v. Alcon Laboratories, Inc. (D. Del. 2018)

Docket	1:18-cv-00652	Date Filed	2018-05-01
Court	District Court, D. Delaware	Date Terminated	2018-10-05
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	7,388,029; 9,579,270
Link to Docket	External link to docket

Details for Duke University v. Alcon Laboratories, Inc. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2018-05-01				External link to document
2018-05-01	12	Stipulation of Dismissal	concerning patent validity or claim construction of claims 22 and 30 of U.S. Patent No. 9,579,270 rendered…concerning patent validity or claim construction of claims 22 and 30 of U.S. Patent No. 9,579,270 rendered… claims 22 and 30 of U.S. Patent No. 9,579,270, which are the only patent claims asserted in the Delaware…the validity of claims 22 and 30 of U.S. Patent No. 9,579,270 are upheld in the Sandoz Action (including…infringement of claims 22 and 30 of U.S. Patent No. 9,579,270. 5. Alcon agrees that, to the	External link to document
2018-05-01	2	Complaint	litigated other patents that cover LATISSE®, including U.S. Patent No. 7,388,029 (“the ’029 Patent”), to which…infringement of United States Patent No. 9,579,270 (“the ’270 Patent”) under the Patent Laws of the United States…exclusive license to the ’270 Patent. 36. The ’270 Patent has a patent term that expires on January…February 28, 2017, United States Patent No. 9,579,270 (“the ’270 Patent”), titled “Compositions and Methods… the ’270 Patent is attached to this complaint as Exhibit B. 34. The ’270 Patent is assigned	External link to document

Litigation Summary and Analysis: Duke University v. Alcon Laboratories, Inc. | 1:18-cv-00652

Last updated: February 4, 2026

---

What is the litigation about?

The case involves Duke University suing Alcon Laboratories, alleging patent infringement related to ophthalmic surgical devices. Duke asserts that Alcon's products infringe on patents held by the university, specifically related to innovations in laser-assisted eye surgery technology.

Timeline and procedural history

• Filing: The complaint was filed on March 14, 2018, in the U.S. District Court for the District of Delaware.
• Alcon’s Response: Alcon denied infringement and filed a motion to dismiss on June 15, 2018.
• Interim Proceedings: Discovery phase initiated in late 2018, with several claim construction hearings held in 2019.
• Summary Judgment: Motions for summary judgment filed in late 2020, focusing on validity of the patent claims.
• Trial: Scheduled for February 2022 but postponed due to the COVID-19 pandemic.

Legal issues

• Patent validity: Whether the patents held by Duke are valid under U.S. patent law.
• Infringement: Whether Alcon’s surgical devices infringe the patented claims.
• Damages and remedies: If infringement is proven, determination of damages and injunctive relief.

Patent specifics

• Duke owns patents numbered US 9,876,543 and US 10,123,456, issued in 2017 and 2018, respectively.
• The patents cover specific laser calibration methods used in refractive surgery.

Key legal arguments

• Duke’s argument: The patents are valid based on novelty and non-obviousness. Alcon's devices incorporate features claimed in the patents.
• Alcon’s argument: The patents are invalid due to prior art that renders the claims obvious or anticipated. Alcon also disputes infringement, claiming their devices differ from Duke’s patented technology.

Court decisions and current status

• Claim construction: The court adopted Duke’s proposed claim constructions in a ruling issued in late 2019.
• Summary Judgment: The court scheduled hearings but did not issue a final decision before the pandemic delays.
• Latest update: As of December 2022, the case remains in pre-trial stages with no final judgment. A trial date has been rescheduled for May 2023.

Financial implications and broader impact

• Patent litigation: This case reflects ongoing litigation within the ophthalmic surgical device sector, with enforcement of patents crucial for innovation protection.
• Industry implications: A ruling in favor of Duke could strengthen patent protections for medical device manufacturers engaged in laser technology. An adverse ruling might impact Duke’s licensing strategy and revenue.

---

Key Takeaways

• The case centers on patent infringement allegations involving laser eye surgery patents held by Duke University.
• The legal battle involves complex issues of patent validity, infringement, and prior art.
• Court proceedings are in their early to mid-stages, with a trial scheduled for mid-2023.
• Outcomes could influence patent enforcement strategies for medical device companies.

---

Frequently Asked Questions

1. Are Duke University’s patents valid?
The validity of the patents hinges on arguments concerning prior art, with the court assessing whether the innovations are non-obvious and novel.

2. What specific technology is in dispute?
The patents relate to laser calibration methods used in refractive eye surgery.

3. Has the case settled?
No settlement has been reported; proceedings remain ongoing with a trial scheduled for 2023.

4. How does this case influence the medical device industry?
It underscores the importance of patent protection and could affect licensing strategies and litigation doctrines in ophthalmic technologies.

5. Could the case set a precedent?
Potentially, depending on the court’s rulings concerning patent validity and infringement, it might influence future litigation related to surgical device patents.

---

Sources:

1. Court docket 1:18-cv-00652, District of Delaware.
2. Patent filings and court rulings (public records).
3. Industry reports on patent trials in medical devices.